In:
Kardiologiia, APO Society of Specialists in Heart Failure, Vol. 60, No. 2 ( 2020-03-05), p. 10-16
Abstract:
Objective. Assess time and possible predictors of restenosis after the implantation of first- and second-generation coronary stents and bare metal stents (BMSs) in patients with stable coronary artery disease after elective coronary stenting. Materials and Methods. From 2010 to 2014, 3,732 (2,897 males, 60 [53; 68] years old) patients with stable exertional angina of functional class I–III underwent coronary stenting. From 2014 to 2017, 1,487 (1,173 males and 314 females) patients returned. Repeat coronary angiography was performed in 699 patients. Results. A total of 644 first-generation stents, 5,321 second-generation stents, and 473 BMSs were implanted. During the control coronary angiography, contrasting was repeated for 193 first-generation stents, 899 second-generation stents, and 77 BMSs. Restenosis (stenosis of 50 % or more in the previously stented segment) was detected in 28 (14 % of angiographic control) first-generation drug-eluting stents, 94 (10 %) second-generation drug-eluting stents, and 21 (27 %) BMSs. Patients with BMS restenosis returned significantly earlier than patients with restenosis of the first- and second-generation drug-eluting stents (11 [6, 27] months vs. 32 [11; 48] ) months and 24 [12; 42] months, respectively; p 〈 0.05). The initial and repeat levels of high-sensitivity C-reactive protein (hs-CRP) were higher in patients with restenosis (2.2 [1.2, 5.0] mg / L vs. 2.1 [1.0, 4.6] mg / L, respectively; p 〉 0.05) than in patients without restenosis (2.0 [0.9, 4.2] mg / L vs. 1.9 [0.7, 3.5] mg / L respectively, p 〉 0.05). Blood levels of hs-CRP ≥2 mg / L according to receiver operating characteristic curve (ROC) analysis at return visit were used as a predictor to identify restenosis of stents with a diameter 〈 3 mm and a length 〉 25 mm – area under the curve (AUC) 0.67 (95 % confidence interval (CI) 0.51–0.84), p 〈 0.05, odds ratio 3.7 (95 % CI 1.1–12.1), p 〈 0.05. Stent type had a significant effect on the time to restenosis in the survival analysis (p 〈 0.0005). Conclusion. The time from coronary stenting to the return visit of patients presenting with restenosis after the implantation of first- and second-generation drug-eluting stents is consistent; median time of the return visit of patients with restenosis of the first-generation stents was 2–3 years after coronary stenting. Blood levels of hs-CRP ≥2 mg / L at the return visit is a predictor of restenosis of stents with a diameter 〈 3 mm and a length 〉 25 mm.
Type of Medium:
Online Resource
ISSN:
2412-5660
,
0022-9040
DOI:
10.18087/cardio.2020.3
DOI:
10.18087/cardio.2020.2.n621
Language:
Unknown
Publisher:
APO Society of Specialists in Heart Failure
Publication Date:
2020
detail.hit.zdb_id:
3005439-4
